Background During neonatal and paediatric high-flow nasal cannula therapy, optimising the
flow setting is crucial for favourable physiological and clinical outcomes. However …

Introduction The use of high flow nasal cannula (HFNC) has become widely used in
pediatric intensive care units (PICUs) throughout the world. The rapid adoption has …

OBJECTIVES: In 2015, the Pediatric Acute Lung Injury Consensus Conference (PALICC)
provided the first pediatric-specific definitions for acute respiratory distress syndrome …

Objectives Bubble CPAP (bCPAP), a non-invasive ventilation modality, has emerged as an
intervention that is able to reduce pneumonia-related mortality in children in low resourced …

Background High‐flow nasal cannula (HFNC) therapy is widely used for children with
bronchiolitis, but its optimal role remains uncertain. Our institution created and later revised …

Background: High flow nasal cannula (HFNC) is commonly used as non-invasive respiratory
support in critically ill children. There are limited data to inform consensus on optimal device …

Objectives Pediatric bilateral vocal cord immobility (BVCI) represents a severe life‐
threatening condition that often causes severe dyspnea. Endoscopic arytenoid lateral …

Objectives To determine whether in infants with bronchiolitis admitted to a pediatric intensive
care unit (PICU) the starting rate for high‐flow nasal cannula (HFNC) therapy set by the …

Objectives To evaluate the effects of four flow rates on the functional residual capacity (FRC)
and pulmonary ventilation distribution while using a high‐flow nasal cannula (HFNC) …

High-flow nasal cannula (HFNC) is becoming the gold standard to treat respiratory distress
at any age since it potentially provides several significant clinical advantages. An obstacle to …